All content for Laboratory Considerations for Clinical Trials is the property of Q Squared Solutions and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This podcast from Q Squared Solutions looks at factors sponsors should consider when preparing for clinical trials.
Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
She describes:
How consent is or has been documented
The benefits of electronic consent documentation
Specific consent attributes, e.g. genetic testing
Handling consent requirements from different countries or institutions
Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix
Laboratory Considerations for Clinical Trials
This podcast from Q Squared Solutions looks at factors sponsors should consider when preparing for clinical trials.
